Repligen Corp
RGEN: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| ?^& | LOCK|v!<@ | LOCK|YQ^xdy$f |
Repligen Earnings: Strong Revenue Growth Across Portfolio Despite Slowdown in New Modalities
Repligen reported year-on-year revenue growth of 22% and adjusted operating margin of 14.2%, which is 70 basis points worse than the same period last year. The company narrowed its full-year guidance ranges and slightly raised its midpoint for revenue growth by 1 percentage point.
